Skip to content
Global Alzheimer’s Platform Foundation
  • Home
  • GAP-Net & Trials
    • GAP-Net
    • Bio-Hermes
    • Apheleia
  • ACTI-V8YB
  • Citizen Scientist Award
    • Awards
    • 2021 Honorees
    • 2020 Honorees
    • 2019 Honorees
    • Participant Spotlight
    • Sponsors
  • News
  • About
    • Leadership & Key Staff
    • Background
    • Global Collaboration
    • Sponsors

About: Taylor

Posts by Taylor:

  • Global Alzheimer’s Platform Foundation Statement on FDA Accelerated Approval of Lecanemab Posted on January 6, 2023 by Taylor Disselhorst in Press Releases
  • Battling The Silent Alzheimer’s EPIDEMIC in The Black Community with Roland Martin Posted on December 28, 2022 by Taylor Disselhorst in In the News
  • GAP President John Dwyer, on Lecanemab detailed results: “There is every reason for the Alzheimer’s community to have optimism today” Posted on November 30, 2022 by Taylor Disselhorst in Press Releases
  • Medicare Alzheimer’s Coverage Policy Advancing Clinical Trial Diversity Efforts Posted on November 29, 2022 by Taylor Disselhorst in In the News
  • An Alzheimer’s Dx Comparison Study Wraps Up, Researchers Plan to Add Genomic Proteomic Profiling Posted on November 22, 2022 by Taylor Disselhorst in In the News
  • Left Out for too Long: New Alzheimer’s Research Focuses on Latinos Posted on November 16, 2022 by Taylor Disselhorst in In the News
  • First of its Kind Head-to-Head Study Comparing Leading Biomarkers for Detecting Alzheimer’s Disease Closes With Unprecedented Representation from Underrepresented Populations Posted on November 15, 2022 by Taylor Disselhorst in Press Releases
  • Statement on Roche Announcement on Gantenerumab Attributed to John Dwyer, GAP Foundation President Posted on November 14, 2022 by Taylor Disselhorst in Press Releases
  • Global Alzheimer’s Platform Foundation (GAP) Supports New Bill from U.S. Representative Vern Buchanan Posted on October 5, 2022 by Taylor Disselhorst in Press Releases
  • Global Alzheimer’s Platform Foundation (GAP) Celebrates Lecanemab’s Positive Clinical Trial Results Posted on September 28, 2022 by Taylor Disselhorst in Press Releases
  • 1
  • 2
  • 3
  • …
  • 19
  • »

Contact Us

Global Alzheimer's Platform Foundation
1101 K Street NW Suite 400
Washington, DC 20005

info@globalalzplatform.org

Follow Us

GAP

© 2023 Global Alzheimer’s Platform Foundation. All rights reserved.